On Friday, as cannabis stocks surged on Wall Street, many in the insurance industry began wondering if a long-awaited expansion in cannabis insurance was finally on the horizon. The excitement followed reports that President Donald Trump might soon sign an executive order to change the federal classification of marijuana. This move would reclassify cannabis from a Schedule I substance, the strictest category alongside drugs like heroin, to a less restrictive Schedule III status, which includes drugs such as steroids and Tylenol with codeine.
This change could open new doors for cannabis businesses, especially in the insurance market. Shares of major cannabis producers like Tilray Brands and Canopy Growth rose by over 40% in New York, while the Amplify Seymour Cannabis ETF jumped about 51%, although it still heads toward its fifth consecutive annual loss.
Currently, marijuana faces tough federal restrictions that make it challenging for insurers to provide coverage. Many big insurance companies have avoided the cannabis sector, fearing legal risks under the current federal ban, which puts marijuana in the same category as heroin. If reclassified to Schedule III, it wouldn’t legalize cannabis fully or erase state laws, but it could reduce federal enforcement and make it easier for insurers to work with cannabis businesses.
Legal experts note that the President cannot change the classification alone but can push federal agencies, like the Justice Department, to speed up the process. If this happens, the insurance industry could begin treating cannabis like other highly regulated sectors such as pharmaceuticals, alcohol, and tobacco. That doesn’t mean underwriting will become simple overnight, but insurers would shift from debating whether to offer coverage to figuring out how best to price and structure it.
Certain types of insurance may see immediate growth if rescheduling happens. These include property and business interruption insurance for cannabis facilities, crop and stock coverage to protect against fire and theft, product liability and recall insurance especially for edibles and vape products, and directors’ and officers’ liability insurance as cannabis companies seek public investment again. Professional indemnity for cannabis-focused service providers and workers’ compensation for employees would also likely expand.
Access to banking is seen as a key factor. Right now, cannabis companies often rely on cash due to federal restrictions on banks serving them. If banks become more willing to work with cannabis businesses, insurers expect clearer financial data, standardized insurance requirements tied to loans, and a more stable customer base. Reinsurers, who have been hesitant due to legal uncertainties, might also reconsider backing cannabis insurance programs if the federal classification changes.
While many in the cannabis industry are hopeful, insurance leaders remain cautious. Rescheduling is not the same as full legalization or comprehensive legislation. The Drug Enforcement Administration still has to complete its rulemaking, and political hurdles remain. Some senior Republicans have expressed skepticism, and a Supreme Court ruling on state versus federal laws could complicate matters.
In the meantime, insurance companies are preparing quietly. Some are reviewing policy language and improving data collection to be ready if demand rises suddenly. There are also concerns about reputational risks since cannabis remains a controversial issue for some customers and boards.
The history of cannabis investing shows how quickly enthusiasm can fade. For example, Tilray’s shares once traded near $2,000 but are now closer to $10. Insurance experts expect the market to grow slowly, starting with specialized carriers before becoming mainstream. This cautious approach is aimed at avoiding past mistakes and building a sustainable industry.
If the administration’s plans proceed and withstand legal and political challenges, cannabis businesses may finally gain access to comprehensive and affordable insurance. Whether this leads to a major boom or steady growth will depend on how quickly the industry proves itself a reliable risk for insurers, as well as future political decisions.